An open-label, single-arm, prospective study to evaluate the lipid-lowering efficacy and safety of simvastatin 40 mg tablet in patients with hypercholesterolemia.
Latest Information Update: 19 Aug 2024
At a glance
- Drugs Simvastatin (Primary)
- Indications Hypercholesterolaemia
- Focus Therapeutic Use
- Sponsors Merck Sharp & Dohme Corp.
- 01 Feb 2007 Status changed from recruiting.
- 13 Dec 2006 New trial record.